2023 annual financial data
Cardiol Therapeutics 2023 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -22,473,162 CAD and net income was -21,222,796 CAD.
Operating cash flow was -25,180,441 CAD.
Get free Cardiol Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -22,473,162 CAD
- Net income
- -21,222,796 CAD
- Operating cash flow
- -25,180,441 CAD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Cardiol Therapeutics financial years